NGEN

NervGen Pharma Corp. Common stock NASDAQ Listed Feb 8, 2021

Healthcare ·Biotechnology ·CA · nervgen.com

$3.60

-3.04% vs $3.71

Mkt Cap $291.1M

52w Low $1.50 43.7% of range 52w High $6.30

50d MA $3.93 200d MA $3.60

P/E (TTM) -6.1x

EV/EBITDA —

P/B 77.1x

Debt/Equity 0.0x

ROE —

P/FCF -13.8x

RSI (14) —

ATR (14) —

Beta 0.99

50d MA $3.93

200d MA $3.60

Avg Volume 211.3K

NervGen Pharma Corp. is a clinical-stage biotechnology company developing therapies aimed at treating nerve damage and neurodegenerative conditions by targeting mechanisms that inhibit nervous system repair.

SIC Code

2834

CIK (SEC)

1751912

Phone

604-336-8089

1455 Bellevue Avenue, Suite 301 · West Vancouver, BC V7T 1C3 · CA

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 31, 2026	BMO	-0.11	-0.26	-125.8%	3.77	+0.5%	+15.6%	-2.3%	+3.1%	-9.6%	+5.3%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 27	H.C. Wainwright	Initiates	Buy	$18	$3.92	$4.04	+3.1%	-1.8%	+0.8%	-3.4%	-3.2%	+4.1%

Data updated apr 26, 2026 2:55pm · Source: massive.com